Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Gilead Sciences (1)

Synspira, Inc. (1)

Collaborator

Intervention

azli (1)

inhaled placebo (1)

inhaled snsp113 (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

burkholderia infections

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lung Diseases, Pulmonary Disease, Cystic Fibrosis Trial in London, Belfast (Inhaled SNSP113, Inhaled Placebo)

Terminated

Lung Diseases
+15 more

Inhaled SNSP113
Inhaled Placebo

London, England, United Kingdom
+1 more

May 23, 2018

Cystic Fibrosis, Burkholderia Infections Trial in Canada, United States (AZLI, Placebo)

Completed

Cystic Fibrosis
Burkholderia Infections

AZLI
Placebo

Mobile, Alabama
+34 more

Feb 7, 2014